← Leaderboards
Alan Michael Krensky
Stanford University
$4,935,704
Attributed
$4,935,704
Total exposure
4
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $747.8K · FY2005–06$1M$750K$500K$250K$0
'05
'06
Funding mix
By agency
NIH$5,721,160 · 5
By mechanism
R37$2,824,818 · 1
R01$1,613,796 · 1
P01$970,518 · 2
R21$312,028 · 1
Top collaborators
No co-investigators on record.
Most similar at Stanford University
Same institution · by research overlap
- Samuel Strober$36,157,957
- Ronald Levy$27,846,042
- Edgar G. Engleman$35,389,843
- Lalita Ramakrishnan$16,324,683
- Olivia M Martinez$20,491,021
Others in their field
Top investigators on “Laboratory Mouse”
- Richard K. Wilson · Washington University$122,948,010
- Frank Patrick McCormick · University Of California San Francisco$87,382,096
- David Heimbrook · Leidos Biomedical Research, Inc.$81,904,667
- Kc Kent Lloyd · University Of California At Davis$56,148,943
- Alfred G Gilman · University Of Texas Sw Med Ctr/Dallas$53,869,943
- Carol J Bult · Jackson Laboratory$47,860,052
Research focus
Laboratory MouseGenetically Modified AnimalsHuman TissueProtein Structure FunctionTransplant RejectionLeukocyte Activation /TransformationSynthetic PeptideDna FootprintingDna Binding ProteinDiagnosis Design /EvaluationT LymphocyteImmunoprecipitationChemokineCytolysisFlow CytometryMolecular CloningNucleic Acid SequenceArtificial ImmunosuppressionGenetic Promoter ElementHomologous TransplantationCellular ImmunityGene ExpressionKidney TransplantationNorthern Blottings
Grant awards (15)
Antigens in CTL-Mediated Transplant Rejection$432,112
R37 · FY2006 · DK · contact PI
Antigens in CTL-Mediated Transplant Rejection$431,899
R37 · FY2005 · DK
Granulysin: A Novel Cytolytic Molecule$315,915
R01 · FY2005 · AI
Antigens in CTL-Mediated Transplant Rejection$421,743
R37 · FY2004 · DK
Granulysin: A Novel Cytolytic Molecule$315,823
R01 · FY2004 · AI
Granulysin: A Novel Cytolytic Molecule$457,311
R01 · FY2003 · AI
Antigens in CTL-Mediated Transplant Rejection$411,418
R37 · FY2003 · DK
Antigens in CTL-Mediated Transplant Rejection$399,361
R37 · FY2002 · DK
Granulysin: A Novel Cytolytic Molecule$284,252
R01 · FY2002 · AI
ANTIGENS IN CTL MEDIATED TRANSPLANT REJECTION$368,569
R37 · FY2001 · DK
Granulysin: A Novel Cytolytic Molecule$312,028
R21 · FY2001 · AI
HLA DERIVED PEPTIDES AS NOVEL IMMUNOSUPPRESSIVES$785,456
P01 · FY2000 · AI
ANTIGENS IN CTL MEDIATED TRANSPLANT REJECTION$359,716
R37 · FY2000 · DK
GRANULYSIN, A NOVEL CYTOLYTIC MOLECULE$240,495
R01 · FY2000 · AI
MECHANISM OF ACTION OF HLA CLASS I PEPTIDES$185,062
P01 · FY2000 · AI